Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsSelling, General & AdministrativeTax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Exozymes (EXOZ) Other Operating Expenses (2023 - 2024)

Exozymes (EXOZ) has disclosed Other Operating Expenses for 2 consecutive years, with -$1.3 million as the latest value for Q4 2024.

  • Quarterly Other Operating Expenses fell 1658.45% to -$1.3 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was -$831030.0 through Dec 2024, changed N/A year-over-year, with the annual reading at $2.8 million for FY2025, 941.75% up from the prior year.
  • Other Operating Expenses for Q4 2024 was -$1.3 million at Exozymes, down from $650886.0 in the prior quarter.
  • The five-year high for Other Operating Expenses was $650886.0 in Q3 2024, with the low at -$1.3 million in Q4 2024.